simoa advantage kit Search Results


simoa alzpath ptau 217 care advantage kit  (Quanterix)
97
Quanterix simoa alzpath ptau 217 care advantage kit
Simoa Alzpath Ptau 217 Care Advantage Kit, supplied by Quanterix, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/Simoa+pTau-217+Advantage+PLUS+Kit/pmc12184040-68-65-74
Average 97 stars, based on 1 article reviews
simoa alzpath ptau 217 care advantage kit - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
simoa sars cov 2 n protein advantage kit assay  (Quanterix)
96
Quanterix simoa sars cov 2 n protein advantage kit assay
Simoa Sars Cov 2 N Protein Advantage Kit Assay, supplied by Quanterix, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/Simoa+%2C+IP-10+Kit/pmc11213952-118-1-8
Average 96 stars, based on 1 article reviews
simoa sars cov 2 n protein advantage kit assay - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
single molecule array simoa nf lighttm advantage kit run  (Quanterix)
96
Quanterix single molecule array simoa nf lighttm advantage kit run
Single Molecule Array Simoa Nf Lighttm Advantage Kit Run, supplied by Quanterix, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/NF-Light+v2+Advantage+Kit/pmc12589760-222-12-25
Average 96 stars, based on 1 article reviews
single molecule array simoa nf lighttm advantage kit run - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
simoa ptau 181 advantage v2 1 kit  (Quanterix)
97
Quanterix simoa ptau 181 advantage v2 1 kit
Correlations of plasma mid-p-tau or N-p-tau level with tau or amyloid PET in the subjects with AD continuum. a The correlation between plasma <t>mid-p-tau181</t> level and 18 F-florzorotau tau PET is depicted through its topographical representation ( P < 0.05, FWE-corrected). b , c Scatter plots of the correlation between plasma mid-p-tau181 level and tau PET tracer accumulation in each ROI. Pearson's correlation analysis was employed to calculate the r and P values. Statistical significance was established at P < 0.0125, corrected for multiple comparisons using the Bonferroni method. Regression analysis, indicated by a straight or curved line, depicts the preferred model, with its goodness of fit quantified using the R 2 value. d Topographical representation of the correlation between plasma N-p-tau181 level and tau PET ( P < 0.05, uncorrected). e , f Scatter plots of the correlation between plasma N-p-tau181 level and tau PET tracer accumulation in each ROI. The procedure for the correlation analysis was the same as that in b and c . g Topographical representation of the correlations of each plasma p-tau181 assay with amyloid- (left column) and tau- (right column) PET in the CN and AD continuum cohort ( P < 0.05, FWE-corrected). h Bar graphs illustrating beta coefficient values of amyloid and tau PET in multiple liner regression analysis with each p-tau assay. * P < 0.05, ** P < 0.005, **** P < 0.0005. P -values were corrected for multiple comparisons using Bonferonni correction with the number of explanatory variables
Simoa Ptau 181 Advantage V2 1 Kit, supplied by Quanterix, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/Tau+2%2E1+Kit/pmc11375937-15-5-10
Average 97 stars, based on 1 article reviews
simoa ptau 181 advantage v2 1 kit - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
serum nfl  (Uman Diagnostics)
86
Uman Diagnostics serum nfl
Correlations of plasma mid-p-tau or N-p-tau level with tau or amyloid PET in the subjects with AD continuum. a The correlation between plasma <t>mid-p-tau181</t> level and 18 F-florzorotau tau PET is depicted through its topographical representation ( P < 0.05, FWE-corrected). b , c Scatter plots of the correlation between plasma mid-p-tau181 level and tau PET tracer accumulation in each ROI. Pearson's correlation analysis was employed to calculate the r and P values. Statistical significance was established at P < 0.0125, corrected for multiple comparisons using the Bonferroni method. Regression analysis, indicated by a straight or curved line, depicts the preferred model, with its goodness of fit quantified using the R 2 value. d Topographical representation of the correlation between plasma N-p-tau181 level and tau PET ( P < 0.05, uncorrected). e , f Scatter plots of the correlation between plasma N-p-tau181 level and tau PET tracer accumulation in each ROI. The procedure for the correlation analysis was the same as that in b and c . g Topographical representation of the correlations of each plasma p-tau181 assay with amyloid- (left column) and tau- (right column) PET in the CN and AD continuum cohort ( P < 0.05, FWE-corrected). h Bar graphs illustrating beta coefficient values of amyloid and tau PET in multiple liner regression analysis with each p-tau assay. * P < 0.05, ** P < 0.005, **** P < 0.0005. P -values were corrected for multiple comparisons using Bonferonni correction with the number of explanatory variables
Serum Nfl, supplied by Uman Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/advantage+kit+light+nf+simoa/pm36768341-310-25-42
Average 86 stars, based on 1 article reviews
serum nfl - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
simoa  (Quanterix)
97
Quanterix simoa
Correlations of plasma mid-p-tau or N-p-tau level with tau or amyloid PET in the subjects with AD continuum. a The correlation between plasma <t>mid-p-tau181</t> level and 18 F-florzorotau tau PET is depicted through its topographical representation ( P < 0.05, FWE-corrected). b , c Scatter plots of the correlation between plasma mid-p-tau181 level and tau PET tracer accumulation in each ROI. Pearson's correlation analysis was employed to calculate the r and P values. Statistical significance was established at P < 0.0125, corrected for multiple comparisons using the Bonferroni method. Regression analysis, indicated by a straight or curved line, depicts the preferred model, with its goodness of fit quantified using the R 2 value. d Topographical representation of the correlation between plasma N-p-tau181 level and tau PET ( P < 0.05, uncorrected). e , f Scatter plots of the correlation between plasma N-p-tau181 level and tau PET tracer accumulation in each ROI. The procedure for the correlation analysis was the same as that in b and c . g Topographical representation of the correlations of each plasma p-tau181 assay with amyloid- (left column) and tau- (right column) PET in the CN and AD continuum cohort ( P < 0.05, FWE-corrected). h Bar graphs illustrating beta coefficient values of amyloid and tau PET in multiple liner regression analysis with each p-tau assay. * P < 0.05, ** P < 0.005, **** P < 0.0005. P -values were corrected for multiple comparisons using Bonferonni correction with the number of explanatory variables
Simoa, supplied by Quanterix, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/simoa/custom%40simoa%4039859463
Average 97 stars, based on 1 article reviews
simoa - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
il-17a advantage plus kit  (Quanterix)
97
Quanterix il-17a advantage plus kit
Correlations of plasma mid-p-tau or N-p-tau level with tau or amyloid PET in the subjects with AD continuum. a The correlation between plasma <t>mid-p-tau181</t> level and 18 F-florzorotau tau PET is depicted through its topographical representation ( P < 0.05, FWE-corrected). b , c Scatter plots of the correlation between plasma mid-p-tau181 level and tau PET tracer accumulation in each ROI. Pearson's correlation analysis was employed to calculate the r and P values. Statistical significance was established at P < 0.0125, corrected for multiple comparisons using the Bonferroni method. Regression analysis, indicated by a straight or curved line, depicts the preferred model, with its goodness of fit quantified using the R 2 value. d Topographical representation of the correlation between plasma N-p-tau181 level and tau PET ( P < 0.05, uncorrected). e , f Scatter plots of the correlation between plasma N-p-tau181 level and tau PET tracer accumulation in each ROI. The procedure for the correlation analysis was the same as that in b and c . g Topographical representation of the correlations of each plasma p-tau181 assay with amyloid- (left column) and tau- (right column) PET in the CN and AD continuum cohort ( P < 0.05, FWE-corrected). h Bar graphs illustrating beta coefficient values of amyloid and tau PET in multiple liner regression analysis with each p-tau assay. * P < 0.05, ** P < 0.005, **** P < 0.0005. P -values were corrected for multiple comparisons using Bonferonni correction with the number of explanatory variables
Il 17a Advantage Plus Kit, supplied by Quanterix, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simoa+advantage+kit/IL-17A+Advantage+PLUS+Kit/custom%40104428%4039731185
Average 97 stars, based on 1 article reviews
il-17a advantage plus kit - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

Image Search Results


Correlations of plasma mid-p-tau or N-p-tau level with tau or amyloid PET in the subjects with AD continuum. a The correlation between plasma mid-p-tau181 level and 18 F-florzorotau tau PET is depicted through its topographical representation ( P < 0.05, FWE-corrected). b , c Scatter plots of the correlation between plasma mid-p-tau181 level and tau PET tracer accumulation in each ROI. Pearson's correlation analysis was employed to calculate the r and P values. Statistical significance was established at P < 0.0125, corrected for multiple comparisons using the Bonferroni method. Regression analysis, indicated by a straight or curved line, depicts the preferred model, with its goodness of fit quantified using the R 2 value. d Topographical representation of the correlation between plasma N-p-tau181 level and tau PET ( P < 0.05, uncorrected). e , f Scatter plots of the correlation between plasma N-p-tau181 level and tau PET tracer accumulation in each ROI. The procedure for the correlation analysis was the same as that in b and c . g Topographical representation of the correlations of each plasma p-tau181 assay with amyloid- (left column) and tau- (right column) PET in the CN and AD continuum cohort ( P < 0.05, FWE-corrected). h Bar graphs illustrating beta coefficient values of amyloid and tau PET in multiple liner regression analysis with each p-tau assay. * P < 0.05, ** P < 0.005, **** P < 0.0005. P -values were corrected for multiple comparisons using Bonferonni correction with the number of explanatory variables

Journal: Translational Neurodegeneration

Article Title: A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease

doi: 10.1186/s40035-024-00439-4

Figure Lengend Snippet: Correlations of plasma mid-p-tau or N-p-tau level with tau or amyloid PET in the subjects with AD continuum. a The correlation between plasma mid-p-tau181 level and 18 F-florzorotau tau PET is depicted through its topographical representation ( P < 0.05, FWE-corrected). b , c Scatter plots of the correlation between plasma mid-p-tau181 level and tau PET tracer accumulation in each ROI. Pearson's correlation analysis was employed to calculate the r and P values. Statistical significance was established at P < 0.0125, corrected for multiple comparisons using the Bonferroni method. Regression analysis, indicated by a straight or curved line, depicts the preferred model, with its goodness of fit quantified using the R 2 value. d Topographical representation of the correlation between plasma N-p-tau181 level and tau PET ( P < 0.05, uncorrected). e , f Scatter plots of the correlation between plasma N-p-tau181 level and tau PET tracer accumulation in each ROI. The procedure for the correlation analysis was the same as that in b and c . g Topographical representation of the correlations of each plasma p-tau181 assay with amyloid- (left column) and tau- (right column) PET in the CN and AD continuum cohort ( P < 0.05, FWE-corrected). h Bar graphs illustrating beta coefficient values of amyloid and tau PET in multiple liner regression analysis with each p-tau assay. * P < 0.05, ** P < 0.005, **** P < 0.0005. P -values were corrected for multiple comparisons using Bonferonni correction with the number of explanatory variables

Article Snippet: Conversely, the conventional N-p-tau181 assay (Simoa pTau-181 Advantage V2.1 kit, Quanterix, MA) showed no significant linear correlations with tau PET tracer retention (Fig. d–f).

Techniques: